Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00330447 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Oncological Treatment During Pregnancy on Mother and Child

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 6, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Eligibility criteria expanded, about 28 words Study description shortened, about 53 words · Site contacts updated at 1 of 33 sites · Collaborators revised (5)v15 Show 3 more changesShow less
    • Study description shortened, about 53 words
    • Site contacts updated at 1 of 33 sites
    • Collaborators revised (5)

    See this version in full on ClinicalTrials.gov ↗

  2. Re-verified, no change to tracked fieldsv14
  3. Study sites revised (33)v13 See this version in full on ClinicalTrials.gov ↗
  4. Study sites: 11 to 33v12
  5. Study sites: 5 to 11 Collaborators: 10 to 5v11 Show 1 more changeShow less
    • Collaborators: 10 to 5

    See this version in full on ClinicalTrials.gov ↗

Show 9 earlier versionsHide 9 earlier versions
  1. Study sites: 1 to 5 Completion date: Apr 2025 to Dec 2032 · Eligibility criteria expanded, about 19 words · Study description expanded, about 237 words · 3 morev10 Show 6 more changesShow less
    • Completion date: Apr 2025 to Dec 2032
    • Eligibility criteria expanded, about 19 words
    • Study description expanded, about 237 words
    • Collaborators: 6 to 10
    • Publications: 42 to 73
    • Study title expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  2. Primary and study completion dates: Apr 2020 to Apr 2025 Publications: 18 to 42 · Eligibility criteria expanded, about 2 wordsv9 Show 2 more changesShow less
    • Publications: 18 to 42
    • Eligibility criteria expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  3. Re-verified, no change to tracked fieldsv8
  4. Enrollment target: 400 to 5000 Primary completion date: Sep 2010 to Apr 2020 · Study description shortened, about 16 words · Site contact updated · 2 morev7 Show 5 more changesShow less
    • Primary completion date: Sep 2010 to Apr 2020
    • Study description shortened, about 16 words
    • Site contact updated
    • Collaborators revised (6)
    • Publications: 10 to 18

    See this version in full on ClinicalTrials.gov ↗

  5. Enrollment target: 100 to 400 Primary completion date: Sep 2010 · Site contact updated · Collaborators revised (6) · 1 morev6 Show 4 more changesShow less
    • Primary completion date: Sep 2010
    • Site contact updated
    • Collaborators revised (6)
    • Publications: 9 to 10

    See this version in full on ClinicalTrials.gov ↗

  6. Collaborators: 7 to 6v5 See this version in full on ClinicalTrials.gov ↗
  7. Eligibility criteria revisedv4 See this version in full on ClinicalTrials.gov ↗
  8. Study description revised Site contact updated · Eligibility criteria expanded, about 3 wordsv3 Show 2 more changesShow less
    • Site contact updated
    • Eligibility criteria expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  9. Enrollment target: 50 to 100 Completion date: Apr 2006 to Apr 2020 · Eligibility criteria expanded, about 8 words · Site contact updated · 2 morev2 Show 5 more changesShow less
    • Completion date: Apr 2006 to Apr 2020
    • Eligibility criteria expanded, about 8 words
    • Site contact updated
    • Study description expanded, about 2 words
    • Study title expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children who were exposed to cancer or cancer treatment (cytotoxic drugs, radiation therapy, targeted therapy,...) develop normally (neurologic and cardiologic examination).
Trial Details
NCT Number NCT00330447
Lead Sponsor University Hospital, Gasthuisberg
Collaborators: The Netherlands Cancer Institute, Erasmus Medical Center, San Gerardo Hospital, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Charles University, Czech Republic
Conditions Cancer, Pregnancy
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov